• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[더바이오] 큐로셀 “계획대로 9월 CAR-T ‘안발셀’ 허가신청…조건부 아닌 정식 절차”

2024/02/21

큐로셀 “계획대로 9월 CAR-T ‘안발셀’ 허가신청…조건부 아닌 정식 절차” < 암 < 기사본문 – 더바이오 (thebionews.net)

Prev[이투데이] 김건수 큐로셀 대표 “국산 CAR-T 상업화·흑자전환 임박” [상장 새내기 바이오①]
Next큐로셀, 차세대 CAR-T 치료제 ‘안발셀’ 임상시험 성공 발표
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.